Equine Protozoal Myeloencephalitis (EPM) remains a challenging neurological disease that impacts horses, often presenting with a range of debilitating symptoms. The pursuit of effective treatments for this complex condition has led to the emergence of Toltrazuril, a potent antiprotozoal medication that has gained considerable popularity.  We delve into the evolving significance of Toltrazuril in managing